AlphaCore Capital LLC Invests $694,000 in The Clorox Company (NYSE:CLX)

AlphaCore Capital LLC bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,276 shares of the company's stock, valued at approximately $694,000.

A number of other hedge funds also recently bought and sold shares of CLX. Redwood Park Advisors LLC bought a new stake in Clorox during the fourth quarter valued at about $26,000. Millstone Evans Group LLC bought a new stake in Clorox during the fourth quarter valued at about $31,000. Asset Planning Inc bought a new stake in Clorox during the fourth quarter valued at about $32,000. GKV Capital Management Co. Inc. bought a new stake in Clorox during the fourth quarter valued at about $32,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in Clorox during the fourth quarter valued at about $33,000. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Evercore ISI set a $140.00 price target on shares of Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Morgan Stanley reduced their target price on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Wells Fargo & Company reduced their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. UBS Group reduced their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $151.23.

Clorox Price Performance

NYSE:CLX traded up $0.37 during mid-day trading on Thursday, hitting $130.53. The company's stock had a trading volume of 593,656 shares, compared to its average volume of 1,335,680. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a market capitalization of $16.09 billion, a price-to-earnings ratio of 35.67, a P/E/G ratio of 2.62 and a beta of 0.60. The stock has a fifty day moving average of $138.75 and a 200-day moving average of $151.70.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same period last year, the company earned $1.71 EPS. The business's revenue for the quarter was down 8.0% on a year-over-year basis. As a group, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was bought at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the acquisition, the director now owns 4,000 shares in the company, valued at approximately $546,280. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.57% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.